NCT02656160View on ClinicalTrials.gov

Effect of Dalfampridine (4-AP) on Genioglossus Muscle Activity in Healthy Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

May 31, 2016

Study Completion Date

July 31, 2016

Conditions
Sleep Apnea, Obstructive
Interventions
DRUG

Placebo

Placebo 3 hrs before sleep

DRUG

Dalfampridine

Dalfampridine 10 mg extended release 3 hrs before sleep

Trial Locations (1)

02115

Sleep Disorders Research Program Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT02656160 - Effect of Dalfampridine (4-AP) on Genioglossus Muscle Activity in Healthy Adults | Biotech Hunter | Biotech Hunter